New Depixus job opening!

Read More

Depixus today opened a new job position! For more details, please visit the Job descriptions

PicoSeq announces corporate name change to Depixus

Read More

PicoSeq announced today that it is changing its corporate name to Depixus. “The name change reflects the company’s breadth of interest across both genetic and epigenetic analysis, with our technology being developed for applications far beyond just DNA sequencing” said Gordon Hamilton, Depixus’ Président (CEO). The new name is effective immediately and will be implemented across the company over…

Chas André joins PicoSeq as Chief Technology Officer

Read More

Effective immediately, Chas André, Ph.D. has joined the PicoSeq leadership team as Chief Technology Officer. Dr. André comes from Thermo Fisher Scientific, where he was R&D Group Manager in Molecular Clinical Diagnostics in Helsinki, Finland. Previously, he has worked for a diverse range of molecular tools companies in Europe and the U.S. He has degrees in Biology and genetics from The…